Avantax Planning Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-386
| Closed | -$209K | – | 452 |
|
|
2024
Q2 | $209K | Sell |
386
-315
| -45% | -$171K | 0.01% | 441 |
|
|
2024
Q1 | $363K | Buy |
701
+8
| +1% | +$4.15K | 0.01% | 334 |
|
|
2023
Q4 | $327K | Sell |
693
-26
| -4% | -$12.3K | 0.01% | 289 |
|
|
2023
Q3 | $313K | Sell |
719
-4
| -0.6% | -$1.74K | 0.01% | 277 |
|
|
2023
Q2 | $321K | Buy |
723
+30
| +4% | +$13.3K | 0.01% | 284 |
|
|
2023
Q1 | $319K | Buy |
693
+7
| +1% | +$3.22K | 0.01% | 281 |
|
|
2022
Q4 | $352K | Sell |
686
-81
| -11% | -$41.6K | 0.01% | 275 |
|
|
2022
Q3 | $348K | Sell |
767
-31
| -4% | -$14.1K | 0.02% | 265 |
|
|
2022
Q2 | $385K | Sell |
798
-28
| -3% | -$13.5K | 0.02% | 245 |
|
|
2022
Q1 | $406K | Buy |
826
+50
| +6% | +$24.6K | 0.02% | 244 |
|
|
2021
Q4 | $360K | Sell |
776
-84
| -10% | -$39K | 0.01% | 250 |
|
|
2021
Q3 | $321K | Hold |
860
| – | – | 0.01% | 244 |
|
|
2021
Q2 | $328K | Buy |
860
+189
| +28% | +$72.1K | 0.02% | 245 |
|
|
2021
Q1 | $241K | Buy |
671
+23
| +4% | +$8.26K | 0.01% | 270 |
|
|
2020
Q4 | $208K | Buy |
+648
| New | +$208K | 0.01% | 269 |
|
|
2018
Q4 | – | Sell |
-251
| Closed | -$69K | – | 527 |
|
|
2018
Q3 | $69K | Buy |
+251
| New | +$69K | 0.01% | 415 |
|
|
2018
Q2 | – | Sell |
-324
| Closed | -$71K | – | 566 |
|
|
2018
Q1 | $71K | Buy |
+324
| New | +$71K | 0.01% | 463 |
|
|
2017
Q4 | – | Sell |
-1,460
| Closed | -$277K | – | 321 |
|
|
2017
Q3 | $277K | Sell |
1,460
-11
| -0.7% | -$2.09K | 0.02% | 292 |
|
|
2017
Q2 | $277K | Buy |
1,471
+63
| +4% | +$11.9K | 0.02% | 267 |
|
|
2017
Q1 | $233K | Buy |
+1,408
| New | +$233K | 0.02% | 288 |
|